Endo International plc reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 451.67 million compared to USD 541.69 million a year ago. Net loss was USD 28.48 million compared to USD 722.17 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 3.05 a year ago. Diluted loss per share from continuing operations was USD 0.12 compared to USD 3.05 a year ago. Basic loss per share was USD 0.12 compared to USD 3.07 a year ago. Diluted loss per share was USD 0.12 compared to USD 3.07 a year ago.
For the nine months, sales was USD 1,513.78 million compared to USD 1,763.06 million a year ago. Net loss was USD 8.32 million compared to USD 2,679.57 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 11.35 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 11.35 a year ago. Basic loss per share was USD 0.04 compared to USD 11.42 a year ago. Diluted loss per share was USD 0.04 compared to USD 11.42 a year ago.